US Patent Issued to INIPHARM on June 2 for "HSD17B13 inhibitors and uses thereof" (Indian, American Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,858, issued on June 2, was assigned to INIPHARM INC. (Bellevue, Wash.).

"HSD17B13 inhibitors and uses thereof" was invented by Joshua Odingo (Bothell, Wash.), Heather Kay Webb Hsu (Seattle), Vincent Florio (Seattle), Subramanyam Janardhan Tantry (Karnataka, India), Rajendra Kristam (Karnataka, India) and Athisayamani Jeyaraj Duraiswamy (Karnataka, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are HSD17B13 inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of liver disease, metabolic disease, or cardiovascular disease, such as NAFLD or NASH,...